Douglas Feinstein

基本信息

Career Trajectory

Bio

Doug Feinstein, Ph.D. (Professor, Anesthesiology; Bioengineering; Cell Biology and Anatomy; Biopharmaceutical Science) studies novel approaches to reduce damage and inflammation in neurodegenerative diseases. Dr. Feinstein is involved in the design of early stage clinical trials for MS and AD. Lastly, investigations on the effect of volatile anesthetics on neuro-inflammation are in progress.

Research Interests

Papers共 358 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Statistically-Robust Model of the Axomyelin Unit under Normal Physiologic Conditions with Application to Disease States

Alexander Gow,Jeffrey L. Dupree,Douglas L. Feinstein,Anne Boullerne

ASN NEUROno. 1 (2025)

Cited0Views0WOSBibtex

Short-term Treatment with Cholestyramine Increases Long-Acting Anticoagulant Rodenticide Clearance from Rabbits Without Affecting Plasma Vitamin K1 Levels or Blood Coagulation

Ruth N. Muchiri, Jackie Rocha, Ankit Tandon, Yongmei Luo Chen, Rebecca Alemani, Intakhar Ahmad, Zachary McDonald,Matthew Lindeblad,Israel Rubinstein,Richard B. van Breemen,Douglas L. Feinstein

Toxicological Sciences (2024)

Cited1Views0WOSBibtex

Investigating the Metabolite Signature of an Altered Oral Microbiota As a Discriminant Factor for Multiple Sclerosis: a Pilot Study

Leo Boussamet,Emmanuel Montassier,Camille Mathe,Alexandra Garcia,Jeremy Morille,Sita Shah,Emilie Dugast,Sandrine Wiertlewski,Mathilde Gourdel,Corinna Bang,Klarissa H. Stuerner, Damien Masson,Arnaud B. Nicot,Nicolas Vince,David-Axel Laplaud,Douglas L. Feinstein,Laureline Berthelot

SCIENTIFIC REPORTSno. 1 (2024)

Cited3Views0WOSNATUREBibtex

Validation of Tag SNPs for Multiple Sclerosis HLA Risk Alleles Across the 1000 Genomes Panel

Anne I. Boullerne,Benjamin Goudey,Julien Paganini,Michael Erlichster,Sujata Gaitonde,Douglas L. Feinstein

Human Immunologyno. 3 (2024): 110790-110790

Cited1Views0WOSBibtex

Neuroinflammation in Alzheimer Disease

Michael T Heneka,Wiesje M van der Flier,Frank Jessen, Jeroen Hoozemanns,Dietmar Rudolf Thal,Delphine Boche,Frederic Brosseron,Charlotte Teunissen,Henrik Zetterberg,Andreas H Jacobs,Paul Edison,Alfredo Ramirez,Carlos Cruchaga,Jean-Charles Lambert,Agustin Ruiz Laza, Jose Vicente Sanchez-Mut,Andre Fischer,Sergio Castro-Gomez,Thor D Stein,Luca Kleineidam,Michael Wagner,Jonas J Neher,Colm Cunningham,Sim K Singhrao,Marco Prinz,Christopher K Glass,Johannes C M Schlachetzki,Oleg Butovsky,Kilian Kleemann, Philip L De Jaeger,Hannah Scheiblich,Guy C Brown,Gary Landreth,Miguel Moutinho,Jaime Grutzendler,Diego Gomez-Nicola,Róisín M McManus,Katrin Andreasson,Christina Ising, Deniz Karabag,Darren J Baker,Shane A Liddelow,Alexei Verkhratsky,Malu Tansey,Alon Monsonego,Ludwig Aigner,Guillaume Dorothée,Klaus-Armin Nave,Mikael Simons,Gabriela Constantin,Neta Rosenzweig,Alberto Pascual,Gabor C Petzold,Jonathan Kipnis,Carmen Venegas,Marco Colonna,Jochen Walter,Andrea J Tenner,M Kerry O'Banion,Joern R Steinert,Douglas L Feinstein,Magdalena Sastre,Kiran Bhaskar,Soyon Hong,Dorothy P Schafer,Todd Golde,Richard M Ransohoff,David Morgan,John Breitner,Renzo Mancuso, Sean-Patrick Riechers

Nature reviews Immunologyno. 5 (2024): 321-352

Cited1Views0WOSNATUREBibtex

The Oral Biome of the Multiple Sclerosis Patient: What Can the Oral and Maxillofacial Surgeon Do to Help

Raza A. Hussain,Douglas Feinstein,Anne Boullerne,Demetrios Skias, Carolyn Bevan, Michael Carrithers

Journal of Oral and Maxillofacial Surgeryno. 9 (2024): S81-S82

Cited0Views0Bibtex

Non-adherence with Long-Term Oral Vitamin K1 Therapy in Acute Long-Acting Anticoagulant Rodenticides Poisoning: a Call for Action

Israel Rubinstein,Malvika Kaul,Douglas L. Feinstein

Toxicology Communicationsno. 1 (2024)

Cited1Views0WOSBibtex

Cholestyramine: an Inexpensive but Overlooked Treatment for Long-Acting Anticoagulant Rodenticide (LAAR) Poisoning

Israel Rubinstein,Malvika Kaul,Douglas L. Feinstein

TOXICOLOGY COMMUNICATIONS（2024）

Cited0Views0Bibtex

Astrocyte Lipocalin-2 Modestly Effects Disease Severity in a Mouse Model of Multiple Sclerosis While Reducing Mature Oligodendrocyte Protein and Mrna Expression

Sergey Kalinin,Douglas L. Feinstein

NEUROSCIENCE LETTERS（2023）

Cited1Views0WOSBibtex

Genetic Deletion of C-Jun Amino-Terminal Kinase 3 (JNK3) Modestly Increases Disease Severity in a Mouse Model of Multiple Sclerosis

Mercedes Priego, Lorena Noriega,Sergey Kalinin, Lisa M. Hoffman,Douglas L. Feinstein,Gerardo Morfini

JOURNAL OF NEUROIMMUNOLOGY（2023）

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Research Professor

Papers共 358 篇Author StatisticsCo-AuthorSimilar Experts